Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design.

Authors :: Vaxman I
Kumar SK
Buadi F
Lacy MQ
Dingli D
Hwa Y
Fonder A
Hobbs M
Hayman S
Kourelis T
Warsame R
Muchtar E
Leung N
Kapoor P
Grogan M
Go R
Lin Y
Gonsalves W
Siddiqui M
Kyle RA
Rajkumar SV
Gertz MA
Dispenzieri A
Source :: Leukemia [Leukemia] 2021 Dec; Vol. 35 (12), pp. 3604-3607. Date of Electronic Publication: 2021 May 21.
Publication Year :: 2021

Subjects :: Clinical Trials as Topic
Humans
Immunoglobulin Light-chain Amyloidosis metabolism
Immunoglobulin Light-chain Amyloidosis pathology
Prognosis
Retrospective Studies
Survival Rate
Biomarkers blood
Immunoglobulin Light-chain Amyloidosis blood
Natriuretic Peptide, Brain blood
Peptide Fragments blood
Troponin T blood

Full Text Access

Tools